Todos Medical Reports Fourth-Quarter and Full-Year 2021 Financial Results and Corporate Updates
01 avr. 2022 11h29 HE
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, April 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions...
Todos Medical Reports Case Study of Patient with Long COVID
31 mars 2022 11h17 HE
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, March 31, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company,...
Billy Blanks® Endorses Todos Medical’s Line of Tollovid® Products
28 mars 2022 08h22 HE
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, March 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company,...
Todos Medical to Present at the Proactive One2One Virtual Forum
17 mars 2022 07h00 HE
|
Todos Medical Ltd.
- Thursday, March 17, 2022 at 2:00 PM – 2:30 PM ET - NEW YORK, NY and Tel Aviv, ISRAEL, March 17, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive...
Todos Medical Completes Acquisition of Key Assets and Intellectual Property from NLC Pharma
16 mars 2022 07h00 HE
|
Todos Medical Ltd.
- Forms new subsidiary, 3CL Pharma, focused on the development and commercialization of 3CL protease-related products including Tollovir™, Tollovid®, Tollovid Daily™ and TolloTest™ for COVID-19 - ...
Todos Medical to Present at the Emerging Growth Conference
15 mars 2022 07h00 HE
|
Todos Medical Ltd.
- Wednesday, March 16, 2022 at 1:30 pm – 2 pm EST - New York, NY and Tel Aviv, ISRAEL, March 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive...
Todos Medical Appoints Greg Meiselbach as Vice President of Government Affairs
08 mars 2022 09h53 HE
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, March 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company,...
Todos Medical and NLC Pharma Announce Primary and Secondary Endpoints Met in NLC-V-01 Phase 2 Clinical Trial of Oral Antiviral 3CL Protease Inhibitor Tollovir™ in the Treatment of Hospitalized COVID-19 Patients
27 janv. 2022 08h23 HE
|
Todos Medical Ltd.
§ Phase 2 Study NLC-V-01 closed early after interim data analysis due to positive clinical efficacy § Primary endpoint of time to clinical improvement reached with average reduction of...
Todos Medical Announces Data Lock in Tollovir Phase 2 Clinical Trial for the Treatment of Hospitalized COVID-19 Patients
24 janv. 2022 08h34 HE
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, Jan. 24, 2022 (GLOBE NEWSWIRE) -- § Clinical Data Will be Released Thursday, January 27th, 2022 via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a...
Pepperdine University Hosts the 22nd Annual Celebrity Flag Football Challenge®, Presented by Todos Medical’s Tollovid®
19 janv. 2022 08h00 HE
|
Todos Medical Ltd.
In support of First Responders, Military Service Members and Boys and Girls Youth Groups MALIBU, CALIFORNIA, Jan. 19, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Working along with the NFL Host...